Latest News
Congratulations on the third straight FDA on-site inspection with zero 483 observations.

 

    Jan. 24-27, 2011-FDA reinspected the production quality management of our company’s Heparin Sodium API. Our company passed the FDA on-site inspection in the third time with zero 483 observations.